๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

New and modified interferon alfas: Preclinical and clinical data

โœ Scribed by Paul Masci; Ronald M. Bukowski; Phillip A. Patten; Blaire L. Osborn; Ernest C. Borden

Publisher
Current Science Inc.
Year
2003
Tongue
English
Weight
308 KB
Volume
5
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Overview of preclinical and clinical stu
Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugs
โœ Charles E. Welander ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 816 KB

Both in vitro and in vivo studies have demonstrated antiproliferative effects of interferon alfa-2b (Intron A; Schering-Plough) when tested with human tumor cells. A clonogenic assay has been widely used to determine its direct antiproliferative effects on human tumor cells in vitro using colony red

New generation smallpox vaccines: a revi
New generation smallpox vaccines: a review of preclinical and clinical data
โœ Andrew W. Artenstein ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB

## Abstract The recognition that smallpox is a potential threat agent of bioterrorism has engendered renewed interest in the development of improved vaccines against this pathogen. The purpose of this paper is to review current data regarding novel approaches to smallpox vaccines in comparison with

New asthma targets: recent clinical and
New asthma targets: recent clinical and preclinical advances
โœ Scott Greenfeder; John C Anthes ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 77 KB

Current asthma therapy is directed at the relief of chronic inflammation or improving lung function through bronchodilation. These approaches treat the overt symptoms of asthma but do not approach underlying causes of the disease. Such therapies have limited efficacy and for a number of patients the